KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Non-Current Assets (2016 - 2026)

Teladoc Health's Non-Current Assets history spans 13 years, with the latest figure at $1.7 billion for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 9.1% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.0 billion, a 7.53% decrease, with the full-year FY2025 number at $1.7 billion, down 6.12% from a year prior.
  • Non-Current Assets hit $1.7 billion in Q1 2026 for Teladoc Health, down from $1.7 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for TDOC hit a ceiling of $9.9 billion in Q1 2022 and a floor of $29.6 million in Q4 2022.
  • Historically, Non-Current Assets has averaged $2.9 billion across 5 years, with a median of $1.9 billion in 2024.
  • The widest YoY moves for Non-Current Assets: up 9694.95% in 2023, down 99.7% in 2023.
  • Tracing TDOC's Non-Current Assets over 5 years: stood at $29.6 million in 2022, then soared by 9694.95% to $2.9 billion in 2023, then tumbled by 36.19% to $1.9 billion in 2024, then dropped by 6.12% to $1.7 billion in 2025, then dropped by 3.69% to $1.7 billion in 2026.
  • Business Quant data shows Non-Current Assets for TDOC at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.8 billion in Q3 2025.